TCPI Plans Strategic Alliance For Private Label Nicotine Patch
This article was originally published in The Tan Sheet
Executive Summary
Technical Chemicals & Products, Inc. plans to develop a "strategic alliance" for its private label nicotine patch. The firm's development of an ANDA for a nicotine patch equivalent to SmithKline Beecham's NicoDerm CQ system is under way, although it has not yet filed an ANDA. Waxman/Hatch marketing exclusivity for SB's nicotine patch expires Aug. 2.
You may also be interested in...
Novartis OTC Habitrol Taking Private Label Tack
Novartis Consumer Health is planning a "major" private label initiative with its newly approved OTC nicotine patches involving Wal-Mart, CVS and Walgreens. The firm intends to later market the product under its original Habitrol name, but the initial focus is in the private label setting. OTC Habitrol was approved Nov. 12.
Novartis OTC Habitrol Taking Private Label Tack
Novartis Consumer Health is planning a "major" private label initiative with its newly approved OTC nicotine patches involving Wal-Mart, CVS and Walgreens. The firm intends to later market the product under its original Habitrol name, but the initial focus is in the private label setting. OTC Habitrol was approved Nov. 12.
Novartis OTC Habitrol Taking Private Label Tack
Novartis Consumer Health is planning a "major" private label initiative with its newly approved OTC nicotine patches involving Wal-Mart, CVS and Walgreens. The firm intends to later market the product under its original Habitrol name, but the initial focus is in the private label setting. OTC Habitrol was approved Nov. 12.